Laurent Fischer
25Patents
7h-index
24Co-inventors
69Inventor score
Filing activity: Jun 6, 1995 → Apr 5, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5800928A | Breathable waterproof film | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5869414A | Breathable waterproof film | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6156567A | Truncated transcriptionally active cytomegalovirus promoters | Chemistry; Metallurgy | 21 | Expired |
| US6090393A | Recombinant canine adenoviruses, method for making and uses thereof | Chemistry; Metallurgy | 18 | Expired |
| US5888597A | Packaging based on a polymer containing polyamide blocks and polyether blocks, for conserving fresh produce | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5840807A | Packaging based on a polymer containing polyamide blocks and polyether blocks, for conserving fresh produce | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6852705B2 | DNA vaccines for farm animals, in particular bovines and porcines | Human Necessities | 12 | Expired |
| US5989561A | Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses | Chemistry; Metallurgy | 4 | Expired |
| US8414882B2 | Leishmania challenge model | Emerging Cross-Sectional Technologies | 3 | Active |
| US8075883B2 | Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome | Human Necessities | 3 | Active |
| US7794736B2 | Canine Leishmania vaccine | Emerging Cross-Sectional Technologies | 3 | Active |
| US7741437B2 | P. ariasi polypeptides, p. perniciosus polypeptides and methods of use | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8097599B2 | Plasmid encoding feline BMP-7 | Chemistry; Metallurgy | 1 | Active |
| US7749497B2 | Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome | Human Necessities | 1 | Active |
| US8871225B2 | Canine leishmania vaccine | Emerging Cross-Sectional Technologies | 1 | Active |
| US8906358B2 | Leishmania challenge model | Emerging Cross-Sectional Technologies | 1 | Active |
| US8603808B2 | Leishmania vaccine using sand fly salivary immunogen | Emerging Cross-Sectional Technologies | 1 | Active |
| US10485857B2 | Heartworm vaccine, methods and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10364274B2 | Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure | Emerging Cross-Sectional Technologies | 0 | Active |
| US9901628B2 | Her2 DNA vaccine as adjunct treatment for cancers in companion animals | Human Necessities | 0 | Active |
| US7771995B2 | Plasmid encoding human BMP-7 | Chemistry; Metallurgy | 0 | Active |
| US9315553B2 | Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure | Emerging Cross-Sectional Technologies | 0 | Active |
| US9040053B2 | Her2 DNA vaccine as adjunct treatment for cancers in companion animals | Human Necessities | 0 | Active |
| US7078388B2 | DNA vaccines for farm animals, in particular bovines and porcines | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9228002B2 | Leishmania vaccine using sand fly salivary immunogen | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.